Alonso A, Torre M D, Beisty J C
Servicio de Anestesiología, Hospital San Millán, Logroño, La Rioja, Médico Adjunto, Spain.
Rev Esp Anestesiol Reanim. 2001 Jun-Jul;48(6):285-7.
Antithrombin III (AT III) deficiency is a rare hereditary disease that predisposes a patient to thromboembolic complications. Anticoagulation is essential for preventing recurrence of thrombi. Concentrated AT III replacement is reserved for acute periods of thromboembolism or moments of increased risk. Hemostatic anomalies are generally considered a contraindication for regional anesthesia, due to the potential risk of spinal hematoma. This paper describes a woman with congenital AT III deficiency and heparin-treated pulmonary embolism whose pregnancy of 29 weeks had to be terminated by cesarean section upon signs of fetal distress. We discuss the pathophysiology and treatment in such cases.
抗凝血酶III(AT III)缺乏症是一种罕见的遗传性疾病,使患者易发生血栓栓塞并发症。抗凝对于预防血栓复发至关重要。浓缩AT III替代疗法仅用于血栓栓塞急性期或风险增加时。由于存在脊髓血肿的潜在风险,止血异常通常被视为区域麻醉的禁忌症。本文描述了一名患有先天性AT III缺乏症且接受肝素治疗的肺栓塞女性患者,其怀孕29周时因出现胎儿窘迫迹象而不得不通过剖宫产终止妊娠。我们讨论了此类病例的病理生理学和治疗方法。